Difference between revisions of "Part:BBa K2933021"
Line 6: | Line 6: | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
− | + | ||
<!-- --> | <!-- --> | ||
Line 14: | Line 14: | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display | ||
− | ===Functional Parameters=== | + | `2===Functional Parameters=== |
<partinfo>BBa_K2933021 parameters</partinfo> | <partinfo>BBa_K2933021 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
+ | ===Usage and Biology=== | ||
+ | Fla.103 is a type of subclass B metal beta-lactamases. The beta lactamases can hydrolyze almost all available beta lactam antibiotics (except aztreonam) clinically, including the broad-spectrum antibiotic carbapenems. Because of the extensive substrate profile of this enzyme, the clinical strains carrying it become a great threat to human life and health.<br> | ||
+ | ==References== | ||
+ | |||
+ | |||
+ | ===Molecular cloning=== | ||
+ | |||
+ | <p style="text-align: center;"> | ||
+ | [[File:Fla.103-PCR.png]]<br> | ||
+ | '''Figure 1.''' (a) The PCR result of NDM-23. (b) The verification results by enzyme digestion. |
Revision as of 13:53, 6 September 2019
subclass B1 metallo-beta-lactamase Fla.103, codon optimized in E. coli
This part encodes a protein called Fla.103, which is a metallo-beta-lactamase of subclass B1.
Sequence and Features
Assembly Compatibility:
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 76
- 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 76
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 558
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 76
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 76
- 1000COMPATIBLE WITH RFC[1000]
Usage and Biology
Fla.103 is a type of subclass B metal beta-lactamases. The beta lactamases can hydrolyze almost all available beta lactam antibiotics (except aztreonam) clinically, including the broad-spectrum antibiotic carbapenems. Because of the extensive substrate profile of this enzyme, the clinical strains carrying it become a great threat to human life and health.
References
Molecular cloning
Figure 1. (a) The PCR result of NDM-23. (b) The verification results by enzyme digestion.